Literature DB >> 33484124

Tofacitinib for the Treatment of Three Immune-mediated Conditions in One Patient: Ulcerative Colitis, Pyoderma Gangrenosum, and Alopecia Areata.

Rocio Sedano1, Vipul Jairath1,2.   

Abstract

Entities:  

Keywords:  JAK inhibitors; alopecia areata; pyoderma gangrenosum; ulcerative colitis

Mesh：

Substances：

Year:  2021        PMID： 33484124     DOI： 10.1093/ibd/izab005

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  1 in total

1.  Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.

Authors:  Scott David Lee; Anand Singla; Jason Harper; Mitra Barahimi; Jeffrey Jacobs; Kendra J Kamp; Kindra Dawn Clark-Snustad
Journal:  Inflamm Bowel Dis       Date:  2022-02-01       Impact factor: 7.290
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.